Typicality: | 0.448 |
Saliency: | 0.464 |
in 36 patients with advanced melanoma | 6 | other |
retrospectively | 4 | manner |
in a third study | 4 | location |
colleague → review → datum | 14 |
colleague → report → datum | 9 |
negative | neutral | positive |
0.085 | 0.862 | 0.054 |
Raw frequency | 23 |
Normalized frequency | 0.464 |
Modifier score | 0.500 |
Perplexity | 173.779 |